Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways

Molecular and Cellular Proteomics

Volumn 10, Issue 12, 2011, Pages

  Zhang, Yaoyang ^a,b   Filiou, Michaela D ^a   Reckow, Stefan ^a   Gormanns, Philipp ^a   Maccarrone, Giuseppina ^a   Kessler, Melanie S ^a,c   Frank, Elisabeth ^a,d   Hambsch, Boris ^a,e   Holsboer, Florian ^a   Landgraf, Rainer ^a   Turck, Christoph W ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF WOLLONGONG   (Australia)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUTAMIC ACID; INOSITOL; NITROGEN 15; TRICARBOXYLIC ACID; CARBONATE DEHYDRATASE II; LACTOYLGLUTATHIONE LYASE; PEPTIDE FRAGMENT; PREALBUMIN; SERUM AMYLOID P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DEPRESSION; MALE; MASS SPECTROMETRY; METABOLOMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TREATMENT RESPONSE; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMISTRY; ENZYMOLOGY; GENETICS; HIPPOCAMPUS; METABOLISM; MOLECULAR GENETICS; MULTIFACTORIAL INHERITANCE; PROTEIN MICROARRAY;

AMINO ACID SEQUENCE; ANIMALS; ANXIETY DISORDERS; BIOLOGICAL MARKERS; CARBONIC ANHYDRASE II; GLUTAMIC ACID; HIPPOCAMPUS; INOSITOL; LACTOYLGLUTATHIONE LYASE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MOLECULAR SEQUENCE DATA; MULTIFACTORIAL INHERITANCE; PEPTIDE FRAGMENTS; PREALBUMIN; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SERUM AMYLOID P-COMPONENT;

EID: 83055163839     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.008110     Document Type: Article

References (86)

1. Krömer, S. A., Kessler, M. S., Milfay, D., Birg, I. N., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J. M., Holsboer, F., Landgraf, R., and Turck, C. W. (2005) Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J. Neurosci. 25, 4375-4384 (Pubitemid 40628782)
2. Ditzen, C., Jastorff, A. M., Kessler, M. S., Bunck, M., Teplytska, L., Erhardt, A., Krömer, S. A., Varadarajulu, J., Targosz, B. S., Sayan-Ayata, E. F., Holsboer, F., Landgraf, R., and Turck, C. W. (2006) Protein biomarkers in a mouse model of extremes in trait anxiety. Mol. Cell. Proteomics 5, 1914-1920 (Pubitemid 44688199)
3. Plomin, R., Haworth, C. M., and Davis, O. S. (2009) Common disorders are quantitative traits. Nat. Rev. Genet. 10, 872-878
4. Wu, C. C., MacCoss, M. J., Howell, K. E., Matthews, D. E., and Yates, J. R., 3rd (2004) Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal. Chem. 76, 4951-4959 (Pubitemid 39180319)
5. Frank, E., Kessler, M. S., Filiou, M. D., Zhang, Y., Maccarrone, G., Reckow, S., Bunck, M., Heumann, H., Turck, C. W., Landgraf, R., and Hambsch, B. (2009) Stable isotope metabolic labeling with a novel N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologies. PLoS ONE 4, e7821
6. McClatchy, D. B., Dong, M. Q., Wu, C. C., Venable, J. D., and Yates, J. R., 3rd (2007) 15N metabolic labeling of mammalian tissue with slow protein turnover. J. Proteome Res. 6, 2005-2010 (Pubitemid 46814521)
7. Cox, B., and Emili, A. (2006) Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. 1, 1872-1878 (Pubitemid 46778056)
8. Eng, J. K., Mccormack, A. L., and Yates, J. R. (1994) An Approach to Correlate Tandem Mass-Spectral Data of Peptides with Amino-Acid-Sequences in a Protein Database. J. Am. Soc. Mass Spectrom. 5, 976-989
9. Zhang, Y., Webhofer, C., Reckow, S., Filiou, M. D., Maccarrone, G., and Turck, C. W. (2009) A MS data search method for improved 15N-labeled protein identification. Proteomics 9, 4265-4270
10. Reiter, L., Claassen, M., Schrimpf, S. P., Jovanovic, M., Schmidt, A., Buhmann, J. M., Hengartner, M. O., and Aebersold, R. (2009) Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry. Mol. Cell. Proteomics 8, 2405-2417
11. Pan, C., Kora, G., McDonald, W. H., Tabb, D. L., VerBerkmoes, N. C., Hurst, G. B., Pelletier, D. A., Samatova, N. F., and Hettich, R. L. (2006) ProRata: A quantitative proteomics program for accurate protein abundance ratio estimation with confidence interval evaluation. Anal. Chem. 78, 7121-7131 (Pubitemid 44607553)
12. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. 57, 289-300
13. Fiehn, O., and Kind, T. (2007) Metabolite profiling in blood plasma. Methods Mol. Biol. 358, 3-17
14. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (Pubitemid 30257031)
15. Pan, C., Kumar, C., Bohl, S., Klingmueller, U., and Mann, M. (2009) Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol. Cell. Proteomics 8, 443-450
16. Team, R. D. C. (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
17. Falcon, S., and Gentleman, R. (2007) Using GOstats to test gene lists for GO term association. Bioinformatics 23, 257-258 (Pubitemid 46189622)
18. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., and Hattori, M. (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res. 32, D277-280 (Pubitemid 38081656)
19. Arnone, D. (2005) Review of the use of Topiramate for treatment of psychiatric disorders. Ann. Gen. Psychiatry 4, 5
20. Sullivan, G. M., Hatterer, J. A., Herbert, J., Chen, X., Roose, S. P., Attia, E., Mann, J. J., Marangell, L. B., Goetz, R. R., and Gorman, J. M. (1999) Low levels of transthyretin in the CSF of depressed patients. Am. J. Psychiatry 156, 710-715 (Pubitemid 29220068)
21. Verwey, N. A., Schuitemaker, A., van der Flier, W. M., Mulder, S. D., Mulder, C., Hack, C. E., Scheltens, P., Blankenstein, M. A., and Veerhuis, R. (2008) Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 26, 522-527
22. Domenici, E., Wille, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., Holsboer, F., Bullmore, E. T., Middleton, L., Merlo-Pich, E., Alexander, R. C., and Muglia, P. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 5, e9166
23. Einat, H., and Belmaker, R. H. (2001) The effects of inositol treatment in animal models of psychiatric disorders. J. Affect. Disord. 62, 113-121 (Pubitemid 32126615)
24. Benjamin, J., Levine, J., Fux, M., Aviv, A., Levy, D., and Belmaker, R. H. (1995) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am. J. Psychiatry 152, 1084-1086
25. Levine, J., Barak, Y., Gonzalves, M., Szor, H., Elizur, A., Kofman, O., and Belmaker, R. H. (1995) Double-blind, controlled trial of inositol treatment of depression. Am. J. Psychiatry 152, 792-794
26. Benjamin, J., Agam, G., Levine, J., Bersudsky, Y., Kofman, O., and Belmaker, R. H. (1995) Inositol treatment in psychiatry. Psychopharmacol Bull. 31, 167-175
27. Fux, M., Levine, J., Aviv, A., and Belmaker, R. H. (1996) Inositol treatment of obsessive-compulsive disorder. Am. J. Psychiatry 153, 1219-1221 (Pubitemid 26299846)
28. Palatnik, A., Frolov, K., Fux, M., and Benjamin, J. (2001) Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J. Clin. Psychopharmacol 21, 335-339 (Pubitemid 32452940)
29. Hashimoto-Gotoh, T., Iwabe, N., Tsujimura, A., Takao, K., and Miyakawa, T. (2009) KF-1 Ubiquitin Ligase: An Anxiety Suppressor. Front Neurosci. 3, 15-24
30. Fioravante, D., Liu, R. Y., and Byrne, J. H. (2008) The ubiquitin-proteasome system is necessary for long-term synaptic depression in Aplysia. J. Neurosci. 28, 10245-10256
31. Hambsch, B., Chen, B. G., Brenndörfer, J., Meyer, M., Avrabos, C., Maccarrone, G., Liu, R. H., Eder, M., Turck, C. W., and Landgraf, R. (2010) Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. J. Neurochem. 113, 1240-1251
32. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. (1995) A Synthetic Inhibitor of the Mitogen-Activated Protein-Kinase Cascade. Proc. Natl Acad. Sci. U. S. A. 92, 7686-7689
33. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595
34. Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., and Panayotou, G. (1996) Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol. 16, 1722-1733 (Pubitemid 26095645)
35. Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A., and Pandey, G. N. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem. 77, 916-928 (Pubitemid 32466788)
36. Feng, P., Guan, Z., Yang, X., and Fang, J. (2003) Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res. 991, 195-205 (Pubitemid 37297949)
37. Gourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., and Taylor, J. R. (2008) Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 63, 353-359
38. Qi, X., Lin, W., Li, J., Li, H., Wang, W., Wang, D., and Sun, M. (2008) Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol. Dis. 31, 278-285
39. Tiraboschi, E., Tardito, D., Kasahara, J., Moraschi, S., Pruneri, P., Gennarelli, M., Racagni, G., and Popoli, M. (2004) Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29, 1831-1840 (Pubitemid 39336795)
40. Qi, X., Lin, W., Wang, D., Pan, Y., Wang, W., and Sun, M. (2009) A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav. Brain Res. 199, 203-209
41. Todorovic, C., Sherrin, T., Pitts, M., Hippel, C., Rayner, M., and Spiess, J. (2009) Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 34, 1416-1426
42. de Kloet, E. R., Joëls, M., and Holsboer, F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475
43. Handwerger, K. (2009) Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv. Rev. Psychiatry 17, 184-205
44. Yu, S., Holsboer, F., and Almeida, O. F. (2008) Neuronal actions of glucocorticoids: focus on depression. J. Steroid Biochem. Mol. Biol. 108, 300-309 (Pubitemid 351179642)
45. Müller, M. B., and Holsboer, F. (2006) Mice with mutations in the HPA-system as models for symptoms of depression. Biol. Psychiatry 59, 1104-1115
46. Ströhle, A., and Holsboer, F. (2003) Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 Suppl 3, S207-214 (Pubitemid 38085139)
47. Zafra, F., Aragón, C., and Giménez, C. (1997) Molecular biology of glycinergic neurotransmission. Mol. Neurobiol. 14, 117-142 (Pubitemid 127500995)
48. Legendre, P. (2001) The glycinergic inhibitory synapse. Cell. Mol. Life Sci. 58, 760-793
49. Kirsch, J. (2006) Glycinergic transmission. Cell Tissue Res. 326, 535-540
50. Xu, T. L., and Gong, N. (2010) Glycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation. Prog. Neurobiol. 91, 348-361
51. Weinberg, M. H. (1945) Aminoacetic acid (glycine) in the treatment of depression. J. Nervous Mental Dis. 102, 601-610
52. Javitt, D. C. (2004) Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry 9, 984-997
53. Harwood, A. J. (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117-126
54. Kaur, C., and Ling, E. A. (2008) Antioxidants and neuroprotection in the adult and developing central nervous system. Curr. Med. Chem. 15, 3068-3080
55. Bouayed, J., Rammal, H., and Soulimani, R. (2009) Oxidative stress and anxiety: Relationship and cellular pathways. Oxid. Med. Cell. Longev. 2, 63-67
56. Adibhatla, R. M., and Hatcher, J. F. (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox. Signal. 12, 125-169
57. Wood, S. J., Yücel, M., Pantelis, C., and Berk, M. (2009) Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann. Acad. Med. Singapore 38, 396-396
58. Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., and Cuenod, M. (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 19, 220-230
59. Tylec, A., Jarzab, A., Stryjecka-Zimmer, M., and Wójcicka, A. (2007) [Stress oxidative in schizophrenia]. Pol. Merkur Lekarski 23, 74-77
60. Andreazza, A. C., Kauer-Sant'anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., and Yatham, L. N. (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 111, 135-144
61. Ng, F., Berk, M., Dean, O., and Bush, A. I. (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 11, 851-876
62. Ersan, S., Bakir, S., Erdal Ersan, E., and Dogan, O. (2006) Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1039-1042 (Pubitemid 43928217)
63. Kuloglu, M., Atmaca, M., Tezcan, E., Gecici, O., Tunckol, H., and Ustundag, B. (2002) Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46, 27-32 (Pubitemid 35002315)
64. Kuloglu, M., Atmaca, M., Tezcan, E., Ustundag, B., and Bulut, S. (2002) Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 46, 186-189 (Pubitemid 36173366)
65. Thurston, J. H., and Hauhart, R. E. (1989) Effect of momentary stress on brain energy metabolism in weanling mice: apparent use of lactate as cerebral metabolic fuel concomitant with a decrease in brain glucose utilization. Metab. Brain Dis. 4, 177-186 (Pubitemid 19231228)
66. Jou, S. H., Chiu, N. Y., and Liu, C. S. (2009) Mitochondrial dysfunction and psychiatric disorders. Chang. Gung Med. J. 32, 370-379
67. Herbert, J., Goodyer, I. M., Grossman, A. B., Hastings, M. H., de Kloet, E. R., Lightman, S. L., Lupien, S. J., Roozendaal, B., and Seckl, J. R. (2006) Do corticosteroids damage the brain? J. Neuroendocrinol. 18, 393-411 (Pubitemid 43670845)
68. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (2002) Neurobiology of depression. Neuron 34, 13-25 (Pubitemid 34270695)
69. Küçükibrahimoǧlu, E., Saygin, M. Z., Calişkan, M., Kaplan, O. K., Unsal, C., and Gören, M. Z. (2009) The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur. J. Clin. Pharmacol. 65, 571-577
70. Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y. T., Appel, M., Rothman, D. L., Krystal, J. H., and Mason, G. F. (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61, 705-713 (Pubitemid 38890805)
71. Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Ashworth, F., Sule, A., Matthews, P. M., and Cowen, P. J. (2007) Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 61, 806-812 (Pubitemid 46330250)
72. Gingrich, J. A. (2005) Oxidative stress is the new stress. Nat. Med. 11, 1281-1282
73. Kim, J. S., Schmid-Burgk, W., Claus, D., and Kornhuber, H. H. (1982) Increased serum glutamate in depressed patients. Arch. Psychiatr. Nervenkr 232, 299-304 (Pubitemid 13124834)
74. Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., and Pettegrew, J. W. (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol. Psychiatry 47, 586-593 (Pubitemid 30169251)
75. Hashimoto, K. (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev. 61, 105-123
76. Skolnick, P., Popik, P., and Trullas, R. (2009) Glutamate-based antidepressants: 20 years on. Trends Pharmacol. Sci. 30, 563-569
77. Boyce-Rustay, J. M., and Holmes, A. (2006) Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 31, 2405-2414 (Pubitemid 44607058)
78. Berton, O., and Nestler, E. J. (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151 (Pubitemid 43151600)
79. Lu, T., Rubio, M. E., and Trussell, L. O. (2008) Glycinergic transmission shaped by the corelease of GABA in a mammalian auditory synapse. Neuron 57, 524-535 (Pubitemid 351273989)
80. Young, A. B., Zukin, S. R., and Snyder, S. H. (1974) Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action. Proc. Natl. Acad. Sci. U.S.A. 71, 2246-2250
81. Chojnacka-Wójcik, E., Klodzinska, A., and Pilc, A. (2001) Glutamate receptor ligands as anxiolytics. Curr. Opin. Investig. Drugs 2, 1112-1119 (Pubitemid 32782621)
82. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225
83. Hauger, R. L., Risbrough, V., Brauns, O., and Dautzenberg, F. M. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 5, 453-479 (Pubitemid 44203356)
84. Hillhouse, E. W., and Grammatopoulos, D. K. (2006) The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 27, 260-286
85. Sananbenesi, F., Fischer, A., Schrick, C., Spiess, J., and Radulovic, J. (2003) Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory. J. Neurosci. 23, 11436-11443 (Pubitemid 37549700)
86. Mackay, T. F., Stone, E. A., and Ayroles, J. F. (2009) The genetics of quantitative traits: challenges and prospects. Nat. Rev. Genet. 10, 565-577